Aligos Therapeutics Company
Aligos Therapeutics is discovering and developing new classes of molecules that interact directly with disease-causing modalities.
Employee Number:
1-10
Funding Status:
IPO
Headquarters:
San Francisco, California, United States
Technology:
Others
Estimated Revenue:
$1M to $10M
Founded Date:
2018
Industry:
PharmTech